NVCR logo

NovoCure Limited (NVCR) Cash from financing

annual CFF:

$90.31M+$74.53M(+472.08%)
December 31, 2024

Summary

  • As of today (May 31, 2025), NVCR annual cash flow from financing activities is $90.31 million, with the most recent change of +$74.53 million (+472.08%) on December 31, 2024.
  • During the last 3 years, NVCR annual CFF has risen by +$64.61 million (+251.39%).
  • NVCR annual CFF is now -79.48% below its all-time high of $440.21 million, reached on December 31, 2020.

Performance

NVCR Cash from financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVCRcash flow metrics

quarterly CFF:

$5.25M+$2.56M(+95.42%)
March 31, 2025

Summary

  • As of today (May 31, 2025), NVCR quarterly cash flow from financing activities is $5.25 million, with the most recent change of +$2.56 million (+95.42%) on March 31, 2025.
  • Over the past year, NVCR quarterly CFF has increased by +$5.03 million (+2363.38%).
  • NVCR quarterly CFF is now -99.08% below its all-time high of $570.85 million, reached on December 31, 2020.

Performance

NVCR quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVCRcash flow metrics

TTM CFF:

$95.35M+$5.03M(+5.57%)
March 31, 2025

Summary

  • As of today (May 31, 2025), NVCR TTM cash flow from financing activities is $95.35 million, with the most recent change of +$5.03 million (+5.57%) on March 31, 2025.
  • Over the past year, NVCR TTM CFF has increased by +$84.55 million (+783.19%).
  • NVCR TTM CFF is now -83.92% below its all-time high of $592.90 million, reached on September 30, 2021.

Performance

NVCR TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVCRcash flow metrics

Cash from financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

NVCR Cash from financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+472.1%+2363.4%+783.2%
3 y3 years+251.4%+67.0%+356.5%
5 y5 years+46.4%+16.5%+93.7%

NVCR Cash from financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+483.0%-94.0%+5147.0%at high+783.2%
5 y5-year-79.5%+483.0%-99.1%+103.7%-83.9%+178.1%
alltimeall time-79.5%+4110.5%-99.1%+103.7%-83.9%+178.1%

NVCR Cash from financing History

DateAnnualQuarterlyTTM
Mar 2025
-
$5.25M(+95.4%)
$95.35M(+5.6%)
Dec 2024
$90.31M(+472.1%)
$2.69M(+2585.0%)
$90.31M(+0.9%)
Sep 2024
-
$100.00K(-99.9%)
$89.54M(-1.2%)
Jun 2024
-
$87.32M(>+9900.0%)
$90.61M(+739.3%)
Mar 2024
-
$213.00K(-88.8%)
$10.80M(-31.6%)
Dec 2023
$15.79M(+1.9%)
$1.91M(+63.1%)
$15.79M(-8.7%)
Sep 2023
-
$1.17M(-84.4%)
$17.29M(-14.9%)
Jun 2023
-
$7.50M(+44.2%)
$20.32M(+15.8%)
Mar 2023
-
$5.20M(+52.6%)
$17.55M(+13.3%)
Dec 2022
$15.49M(-39.7%)
$3.41M(-18.9%)
$15.49M(-1.5%)
Sep 2022
-
$4.20M(-11.2%)
$15.73M(+8.0%)
Jun 2022
-
$4.74M(+50.8%)
$14.56M(-30.3%)
Mar 2022
-
$3.14M(-14.0%)
$20.89M(-18.7%)
Dec 2021
$25.70M(-94.2%)
$3.65M(+20.3%)
$25.70M(-95.7%)
Sep 2021
-
$3.04M(-72.5%)
$592.90M(+31.9%)
Jun 2021
-
$11.06M(+39.0%)
$449.38M(+1.3%)
Mar 2021
-
$7.96M(-98.6%)
$443.66M(+0.8%)
Dec 2020
$440.21M(+613.7%)
$570.85M(-506.3%)
$440.21M(-460.7%)
Sep 2020
-
-$140.49M(-2728.5%)
-$122.06M(-460.0%)
Jun 2020
-
$5.34M(+18.7%)
$33.90M(-31.1%)
Mar 2020
-
$4.50M(-47.6%)
$49.21M(-20.2%)
DateAnnualQuarterlyTTM
Dec 2019
$61.68M(-11.1%)
$8.59M(-44.5%)
$61.68M(+10.8%)
Sep 2019
-
$15.47M(-25.1%)
$55.66M(+26.2%)
Jun 2019
-
$20.66M(+21.7%)
$44.09M(+27.3%)
Mar 2019
-
$16.97M(+561.6%)
$34.63M(-50.1%)
Dec 2018
$69.37M(+1242.3%)
$2.56M(-34.3%)
$69.37M(+1.8%)
Sep 2018
-
$3.90M(-65.1%)
$68.13M(+3.3%)
Jun 2018
-
$11.19M(-78.4%)
$65.94M(+16.1%)
Mar 2018
-
$51.71M(+3791.2%)
$56.82M(+999.5%)
Dec 2017
$5.17M(-93.1%)
$1.33M(-22.4%)
$5.17M(+0.0%)
Sep 2017
-
$1.71M(-17.1%)
$5.17M(-93.2%)
Jun 2017
-
$2.07M(+3403.4%)
$76.31M(+1.6%)
Mar 2017
-
$59.00K(-95.6%)
$75.14M(+0.0%)
Dec 2016
$75.12M(-72.9%)
$1.33M(-98.2%)
$75.12M(-68.0%)
Sep 2016
-
$72.85M(+7976.8%)
$235.05M(+46.2%)
Jun 2016
-
$902.00K(+2100.0%)
$160.76M(-36.5%)
Mar 2016
-
$41.00K(-100.0%)
$253.24M(-8.6%)
Dec 2015
$276.99M(>+9900.0%)
$161.26M(<-9900.0%)
$276.99M(+139.3%)
Sep 2015
-
-$1.44M(-101.5%)
$115.73M(-1.2%)
Jun 2015
-
$93.39M(+292.6%)
$117.17M(+392.6%)
Mar 2015
-
$23.79M
$23.79M
Dec 2014
$2.15M(-98.8%)
-
-
Dec 2013
$183.32M
-
-

FAQ

  • What is NovoCure Limited annual cash flow from financing activities?
  • What is the all time high annual CFF for NovoCure Limited?
  • What is NovoCure Limited annual CFF year-on-year change?
  • What is NovoCure Limited quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for NovoCure Limited?
  • What is NovoCure Limited quarterly CFF year-on-year change?
  • What is NovoCure Limited TTM cash flow from financing activities?
  • What is the all time high TTM CFF for NovoCure Limited?
  • What is NovoCure Limited TTM CFF year-on-year change?

What is NovoCure Limited annual cash flow from financing activities?

The current annual CFF of NVCR is $90.31M

What is the all time high annual CFF for NovoCure Limited?

NovoCure Limited all-time high annual cash flow from financing activities is $440.21M

What is NovoCure Limited annual CFF year-on-year change?

Over the past year, NVCR annual cash flow from financing activities has changed by +$74.53M (+472.08%)

What is NovoCure Limited quarterly cash flow from financing activities?

The current quarterly CFF of NVCR is $5.25M

What is the all time high quarterly CFF for NovoCure Limited?

NovoCure Limited all-time high quarterly cash flow from financing activities is $570.85M

What is NovoCure Limited quarterly CFF year-on-year change?

Over the past year, NVCR quarterly cash flow from financing activities has changed by +$5.03M (+2363.38%)

What is NovoCure Limited TTM cash flow from financing activities?

The current TTM CFF of NVCR is $95.35M

What is the all time high TTM CFF for NovoCure Limited?

NovoCure Limited all-time high TTM cash flow from financing activities is $592.90M

What is NovoCure Limited TTM CFF year-on-year change?

Over the past year, NVCR TTM cash flow from financing activities has changed by +$84.55M (+783.19%)
On this page